DT2216 + Paclitaxel in Platinum-Resistant Ovarian Cancer

Clinical trial NCT06964009 · RECRUITING

Trial details

NCT number: NCT06964009
Sponsor: Elizabeth Stover, MD, PhD
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Ovarian Cancer Ovarian Carcinoma Recurrent Ovary Cancer Recurrent Platinum-Resistant Ovarian Carcinoma

Start date: 2025-09-22
Primary completion: 2026-12-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.